Candriam S.C.A. Amgen Inc Transaction History

Candriam S.C.A.

$17.1 Billion
Q3 2024

A detailed history of Candriam S.C.A. transactions in Amgen Inc stock. As of the latest transaction made, Candriam S.C.A. holds 813,096 shares of AMGN stock, worth $215 Million. This represents 1.53% of its overall portfolio holdings.

Number of Shares

813,096

Previous 610,168 33.26%

Holding current value

$215 Million

Previous $191 Million 37.42%

% of portfolio

1.53%

Previous 1.17%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$309.38 - $337.38 $62.8 Million - $68.5 Million	202,928 Added 33.26%	813,096 $262 Million
Q2 2024 Aug 05, 2024	SELL	$262.75 - $319.31 $20.5 Million - $25 Million	-78,192 Reduced 11.36%	610,168 $191 Million
Q1 2024 May 03, 2024	SELL	$268.87 - $324.56 $19.1 Million - $23.1 Million	-71,061 Reduced 9.36%	688,360 $196 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $26.2 Million - $29.5 Million	-102,316 Reduced 11.87%	759,421 $219 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $36.4 Million - $45.2 Million	166,615 Added 23.97%	861,737 $232 Million
Q2 2023 Aug 08, 2023	SELL	$214.27 - $253.37 $66.6 Million - $78.7 Million	-310,684 Reduced 30.89%	695,122 $154 Million
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $5.88 Million - $7.16 Million	26,020 Added 2.66%	1,005,806 $243 Million
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $3.17 Million - $4.03 Million	13,861 Added 1.43%	979,786 $257 Million
Q3 2022 Nov 10, 2022	BUY	$224.46 - $253.15 $6.74 Million - $7.6 Million	30,010 Added 3.21%	965,925 $218 Million
Q2 2022 Aug 03, 2022	BUY	$230.71 - $256.74 $503,409 - $560,206	2,182 Added 0.23%	935,915 $228 Million
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $49 Million - $54.2 Million	-223,380 Reduced 19.3%	933,733 $226 Million
Q4 2021 Feb 10, 2022	BUY	$198.88 - $227.6 $9.41 Million - $10.8 Million	47,309 Added 4.26%	1,157,113 $260 Million
Q3 2021 Nov 09, 2021	BUY	$212.27 - $248.7 $31 Million - $36.3 Million	146,147 Added 15.17%	1,109,804 $236 Million
Q2 2021 Jul 20, 2021	SELL	$233.58 - $259.14 $84.2 Million - $93.4 Million	-360,548 Reduced 27.23%	963,657 $235 Million
Q1 2021 Apr 29, 2021	BUY	$221.91 - $258.6 $3,328 - $3,879	15 Added 0.0%	1,324,205 $292 Million
Q4 2020 Jan 22, 2021	BUY	$216.38 - $257.67 $13.4 Million - $15.9 Million	61,831 Added 4.9%	1,324,190 $304 Million
Q3 2020 Oct 19, 2020	BUY	$234.65 - $260.95 $91.8 Million - $102 Million	391,069 Added 44.88%	1,262,359 $321 Million
Q2 2020 Jul 23, 2020	SELL	$197.81 - $242.74 $6.66 Million - $8.17 Million	-33,678 Reduced 3.72%	871,290 $206 Million
Q1 2020 May 26, 2020	BUY	$182.24 - $241.7 $3,644 - $4,834	20 Added 0.0%	904,968 $213 Million
Q4 2019 Jan 21, 2020	SELL	$189.21 - $243.2 $649,368 - $834,662	-3,432 Reduced 0.38%	904,948 $218,000
Q3 2019 Feb 05, 2020	SELL	$174.11 - $208.62 $1,044 - $1,251	-6 Reduced -0.0%	908,380 $176 Million
Q3 2019 Oct 21, 2019	SELL	$174.11 - $208.62 $19.7 Million - $23.6 Million	-113,219 Reduced 11.08%	908,386 $177,000
Q2 2019 Aug 01, 2019	BUY	$166.7 - $195.41 $1.11 Million - $1.3 Million	6,646 Added 0.65%	1,021,605 $189 Million
Q1 2019 May 02, 2019	BUY	$180.87 - $203.88 $6.94 Million - $7.83 Million	38,384 Added 3.93%	1,014,959 $194 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $17.6 Million - $20.5 Million	-98,475 Reduced 9.16%	976,575 $190 Million
Q3 2018 Nov 07, 2018	BUY	$185.29 - $208.89 $70.5 Million - $79.5 Million	380,562 Added 54.8%	1,075,050 $223 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $8.48 Million - $9.52 Million	51,039 Added 7.93%	694,488 $128 Million
Q1 2018 May 09, 2018	BUY	$169.43 - $198.0 $3.17 Million - $3.7 Million	18,702 Added 2.99%	643,449 $110 Million
Q4 2017 Feb 07, 2018	BUY	$168.79 - $188.59 $27.2 Million - $30.4 Million	161,172 Added 34.77%	624,747 $109 Million
Q3 2017 Nov 03, 2017	BUY	$167.29 - $191.0 $77.6 Million - $88.5 Million	463,575	463,575 $86.4 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account